Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19407231.
- Also identified by DOI 10.1161/STROKEAHA.108.544346.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to study the effect of Botulinum toxin type A (BoNT-A) injections in spastic upper limb muscles on impairment, activity, participation and quality of life in chronic stroke patients. BoNT-A (Dysport) was injected into several upper limb spastic muscles in a group of 20 patients. Neurological impairment (muscle tone and strength, dexterity, SIAS), activity (ABILHAND), participation (SATIS-Stroke), and quality of life (SF36) were assessed before and 2 months after the injections. BoNT-A injections improved muscle tone, but had no impact on dexterity, manual ability, social participation, and quality of life. In this study, BoNT-A injections in spastic upper limbs significantly reduced neurological impairments, but had no functional impact.
Medical subject headings
- Activities of Daily Living
- Botulinum Toxins, Type A
- Interpersonal Relations
- Muscle, Skeletal
- Neuromuscular Agents
- Quality of Life
- Stroke